This page includes the latest FDA filings for Stemline Therapeutics Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | STML | DUNS 139606136 |
Device Company | Device | Date |
|---|---|---|
| Stemline Therapeutics, Inc. | Prescription Medication | 2023-11-23 |
| Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2023-08-04 |
| Stemline Therapeutics, Inc. | Prescription Medication | 2023-02-10 |
| Stemline Therapeutics, Inc. | Prescription Medication | 2023-02-07 |
STEMLINE THERAPEUTICS INC | 2023-02-03 22:03:41 | |
| Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2022-11-15 |
| Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2022-11-10 |
| Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2022-02-01 |
| Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2020-06-10 |
| Stemline Therapeutics, Inc., Alcami Carolinas Corporation | Prescription Medication | 2019-02-26 |
| Stemline Therapeutics, Inc. | Elzonris | 2019-01-18 |
STEMLINE THERAPEUTICS INC | 0000-00-00 00:00:00 |
| NCAGE Code | 4CJM1 | STEMLINE THERAPEUTICS, INC. |
| CAGE Code | 4CJM1 | STEMLINE THERAPEUTICS, INC. |
| S.A.M. Registration | 4CJM1 [139606136] | STEMLINE THERAPEUTICS, INC. |
| SEC | 0001264587 | STEMLINE THERAPEUTICS INC of DELAWARE |